Vaccines are efficient and cost-effective weapons against infectious diseases. The Infection Biology Laboratory of Andreas Meyerhans is partner in a consortium headed by Felipe Garcia, IDIBAPS, Barcelona, that aims to develop a vaccine against SARS-CoV-2. The consortium consists of a multi-disciplinary team of researchers covering bioinformatics, protein structure dynamics simulation, nanoparticle formulations, molecular biology, virology, immunology and infectious diseases. The vaccine is sought to be mRNA/MVA-based and induce protective B cell and T cell immune responses in humans.
The project is supported by a grant from the Generalitat de Catalunya.